Precision Prevention Meeting
ARE YOU A BRCA MUTATION CARRIER? DO YOU HAVE LYNCH OR LI FRAUMENI SYNDROME?
Would you like to help Oxford University plan its cancer prevention strategy? At Oxford University we are developing clinical trials for those at the highest risk of cancer. These studies test new treatments to prevent or delay cancer.
We need your help to find out what studies you would like to see developed.
If you have personal or family history of the conditions listed below, come and share your ideas about the type of treatments you would like to see.
- BRCA mutation
- Lynch Syndrome
- Li Fraumeni Syndrome (LFS)
- Other cancer predisposing conditions
The meeting will be held on Wednesday 21st September at 4pm via zoom
This meeting is organised by the Oncology Clinical Trials Office, and supported by Oxford Cancer.
The meeting will be hosted by Professor Sarah Blagden and seeks to identify the risk attitudes to treatments which aim to prevent or delay cancers for individuals with known BRCA mutations, Lynch Syndrome, Li Fraumeni Syndrome (LFS) or other cancer predisposing conditions.
If you would like to join our meeting then you can sign up below.
Registration for this is hosted on Eventbrite and you will be emailed the zoom link ahead of the meeting on Wednesday 21 September